MLTX CLASS ACTION: MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Stock Plummets 90% — Investors Urged to Contact BFA Law
MLTX CLASS ACTION: MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Stock Plummets 90% — Investors Urged to Contact BFA Law GlobeNewswire October 24, 2025 NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) […]